Treatment
Medication clinical trials
We’re tracking 7,458 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT05837286Recruiting
Conservative care for trigger finger after steroid shots
This study looks at non-surgical (conservative) treatment options for trigger finger after you’ve already had a cortisone shot in the affected finger(s). It may help determine what approach works best to reduce symptoms without more invasive procedures.
Los Angeles, CaliforniaAges 18–100 - NCT05839678Recruiting
Diagnosing and treating cysts in the front chest
This study focuses on how to tell different types of cysts in the front part of the chest (the anterior mediastinum) apart, and how to manage them. It may help by using results to improve diagnosis and treatment decisions for people with thymic, bronchogenic, pericardial, or similar cysts.
Maastricht, LimburgAges 18 years+ - NCT05839834Recruiting
Blood test to detect cancer using RNA
This study checks whether a blood-based test that looks at “RNA signals” can detect cancer. If you qualify, you may have extra blood taken to help test how accurate the method is.
Wuhan, HubeiAges 18–90 - NCT05842239Recruiting
Hyperbaric oxygen therapy for low sperm count infertility
This trial tests whether breathing 100% oxygen in a pressurized chamber (hyperbaric oxygen therapy) can improve fertility in men who have an unexplained low sperm count. It may help by improving sperm health, but you would need multiple sperm tests and to be able to follow the clinic schedule.
ẔerifinAges 21 years+ - NCT05843968RecruitingPhase 2
Rituximab or mycophenolate for steroid-dependent childhood kidney syndrome
This trial tests whether rituximab works as well as mycophenolate in children whose nephrotic syndrome (kidney condition) comes back when steroid medicines are reduced. It aims to find the safest and most effective option during a relapse.
Chongqing, Chongqing MunicipalityAges 3–16 - NCT05844384Recruiting
Testing a new eye drop bottle for glaucoma
This study checks whether a device called the Nanodropper helps deliver glaucoma medicine as well as standard use. It is for adults with stable primary open-angle glaucoma (or ocular hypertension) who are on a limited number of eye-pressure medicines.
Lackland Air Force Base, TexasAges 18 years+ - NCT05845424RecruitingPhase 4
High-intensity cholesterol pills for people with silent calcium
This trial studies whether high-intensity statin plus ezetimibe can improve heart health in people who do not have symptoms but have calcium buildup in their heart arteries. It may help lower cholesterol and reduce future heart risks for the right participants.
SeoulAges 40 years+ - NCT05845723RecruitingPhase 2
Study drugs for blood-vessel Behçet’s to reduce inflammation
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
Beijing, Beijing MunicipalityAges 18–65 - NCT05848570Recruiting
Digital program for reducing HIV risk in SGM youth
This trial tests a digital health program (available with limited in-person contact) to help SGM young people reduce their risk of HIV. You may be a good fit if you’re in the right age range and have had certain types of sex in the last 6 months.
Chicago, IllinoisAges 13–34 - NCT05849077Recruiting
Testing oxygen saturation targets during newborn resuscitation
This study looks at the best oxygen saturation targets and resuscitation approach for very premature babies right after birth. It may help clinicians guide breathing support more safely in the first minutes of life.
Dallas, TexasAges birth–10 minutes - NCT05849844Recruiting
Study for children and adults with a persistent ear tube or small hole
This study looks at Tympanoseal for people who still have a childhood ear tube or a small eardrum hole. It may help protect the ear and improve healing, while researchers compare outcomes using a standardized approach.
Farmington Hills, MichiganAges 2–100 - NCT05851053Recruiting
Study of heart function years after breast cancer treatment
This study checks how well your heart works long after breast cancer treatment. If you joined the earlier de BLOC-I study, you may be invited for follow-up to understand long-term heart effects.
GroningenAges Any age - NCT05851534Recruiting
Pre-surgery risk reduction for pancreatic surgery
This study helps people going for planned pancreatic cancer surgery (with or without chemo beforehand) by focusing on controllable risk factors before the operation. The goal is to improve safety and outcomes after surgery.
's-HertogenboschAges 18 years+ - NCT05851989Recruiting
Studying outcomes after burst brain blood vessel aneurysms
This study looks at what happens over time after a burst brain blood vessel aneurysm that caused bleeding around the brain. Your care team may use the study results to better predict outcomes and guide treatment for people like you.
AmsterdamAges 18 years+ - NCT05851508RecruitingPhase 3
Steroid ear injections for vertigo in one-ear Ménière’s
This Phase 3 study compares injections of steroid medicine into the ear versus a dummy (placebo) injection to see if it reduces vertigo attacks in people with Ménière’s disease. It may help by improving balance symptoms and reducing how often attacks happen.
Leiden, South HollandAges 18–100 - NCT05851976RecruitingPhase 4
Duloxetine for short-term non-radiating low back pain
This trial tests duloxetine (a medicine used for certain pain conditions and mood) for easing low back pain that started recently and doesn’t shoot down your leg. It may help reduce pain and improve daily function after an ER visit, but you must meet several safety and medication-use criteria.
The Bronx, New YorkAges 18–64 - NCT05853796Recruiting
Studying stroke warning signs in young adults
This observational study follows people ages 18–50 who had a first TIA (“mini-stroke”) or an acute ischemic stroke to better understand what happens after the event. It may help improve future care by tracking symptoms, imaging findings, and recovery over time.
Nijmegen, GelderlandAges 18–50 - NCT05855369RecruitingPhase 2/Phase 3
Smell training plus brain stimulation for long COVID smell loss
This study tests whether a combination of smell training and a type of nerve stimulation can improve persistent smell problems after COVID. It is meant for people who had normal smell before COVID and still struggle with smell changes months later.
Charleston, South CarolinaAges 18–65 - NCT05855941Recruiting
Imaging tests to better predict and diagnose gynecologic cancers
This trial studies how well medical imaging (especially MRI) can help predict outcomes and improve diagnosis in people newly diagnosed with certain gynecologic cancers. It may help doctors make more accurate treatment decisions by comparing imaging results to the final cancer type and stage.
UmeåAges 18 years+ - NCT05855954Recruiting
Early kidney protection during heart surgery
This trial looks at whether a specific heart-surgery technique (called CLCVP) can help protect kidney function soon after surgery. It is mainly for adults with otherwise normal kidney tests before certain types of heart operations.
Nanjing, JiangsuAges 18 years+ - NCT05856643RecruitingEarly Phase 1
Study drug for ovarian cancer after prior treatment failure
This early-phase study tests SZ011 in people with ovarian epithelial cancer that has come back or did not respond to standard first treatment. You may qualify if your tumor shows a specific marker (mesothelin) and your health tests are strong enough to safely receive the study drug.
Shantou, GuangdongAges 18–80 - NCT05857891Recruiting
Erythropoietin to help clear lung fluid in ARDS
This trial tests whether erythropoietin (EPO), a medicine that affects red blood cell production, can help clear extra fluid from the lungs in people with acute respiratory distress syndrome (ARDS). If it works, it could improve breathing and reduce lung fluid buildup during critical illness.
Wenzhou, ZhejiangAges 18 years+ - NCT05860400Recruiting
Testing add-on treatment to calm artery inflammation after heart procedures
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05863754Recruiting
Networked device that helps assess hand muscle movement
This trial tests a networked neuroprosthesis device designed to interact with nerves in the arm/hand to help assess grasp and release movements. It may help people with certain long-term spinal cord injuries regain more controlled hand function and researchers measure how well the system works.
Cleveland, OhioAges 16 years+
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,458 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.